Evaluation of Serum Cortisol Level, Hepatitis B and C Virus Infection and Elevated Aminotransferase Enzymes in a Group of Patients with Oral Lichen Planus

Year 2024, Volume: 14 Issue: 4, 889 - 894, 29.12.2024

Hakan Yülek , Filiz Mediha Namdar Pekiner

https://doi.org/10.33808/clinexphealthsci.1491324

Abstract

Objective: Oral Lichen planus (OLP) is a common oral disease that can be caused by a variety of circumstances, including the hepatitis B and C virus (HCV). Stress, as a psychological component, raises cortisol levels, which is linked to a cytokine imbalance that may predispose to the development of autoimmune disorders. An association between OLP and serum cortisol levels has been also widely established. In this study, we aimed to evaluate the relationship of serum cortisol levels, hepatitis B/C virus infections and alanine transaminase (ALT), aspartate transaminase (AST) in patients with oral lichen planus and to compare to healthy controls.
Method: Forty adult patients with OLP and 40 age gender matched healthy controls were participated in the study. All patients were subjected to routine blood test and the estimation of serum cortisol levels, detection of anti-HCV antibody, hepatitis B surface antigen (HBsAg), alanine transaminase (ALT), aspartate transaminase (AST) by using the enzyme immunoassay. The data were statistically analyzed using Student-t, Mann-Whitney U, Chi-Square and Fischer’s Exact test.
Results: Serum cortisol level of OLP patients was found to be 13.38±5.93, and that of the control group was 12.80±3.93. The OLP patients’ ALT-AST levels were 19.91±10.66, 20.81±9.85, and those of the control group were 19.91±10.66, 20.81±9.85, respectively. There was no statistical difference of serum cortisol levels, hepatitis B/C virus infections and ALT-AST levels in OLP patient compared to the healthy control group (p>.05).
Conclusion: This study identified that there was no association between OLP and healthy controls regarding elevated serum cortisol levels, hepatitis B/C virus infection and aminotransferaze enzymes.

Keywords

Oral lichen planus, oral mucosal diseases, hepatitis, serum cortisol

Ethical Statement

This study was approved by Ethics Committee of Marmara University, Faculty of medicine, Clinic Ethics Committee (Approval date: 28.07.2022; Number: 09.2022.999)

Supporting Institution

TÜBİTAK

Project Number

This research is based on PhD thesis of Dr. Hakan Yülek and supported by TUBİTAK with Project number 123S550.

Thanks

This research is based on PhD thesis of Dr. Hakan Yülek and supported by TUBİTAK with Project number 123S550.

References

• Epstein JB, Wan LS, Gorsky M, Zhang L. Oral lichen planus: Progress in understanding its malignant potential and the implications for clinical management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;96(1):32-37. DOI: 10.1016/s1079-2104(03)00161-6.
• Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K. Current controversies in oral lichen planus: Report of an international consensus meeting. Part 2. Clinical management and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100(2):164-178. DOI: 10.1016/j.tripleo.2004.06.076.
• Fitzpatrick SG, Hirsch SA, Gordon SC. The malignant transformation of oral lichen planus and oral lichenoid lesions: A systematic review. J Am Dent Assoc. 2014;145(1):45-56. DOI: 10.14219/jada.2013.10.
• Pekiner FN, Demirel GY, Borahan MO, Ozbayrak S. Evaluation of cytotoxic T-cell activation, chemokine receptors, and adhesion molecules in blood and serum in patients with oral lichen planus. J Oral Pathol Med. 2012;41(6):484-489. DOI: 10.1111/j.1600-0714.2012. 01130.x.
• Pekiner FN, Demirel GY, Borahan MO, Özbayrak S. Cytokine profiles in serum of patients with oral lichen planus. Cytokine. 2012;60(3):701-706. DOI: 10.1016/j.cyto.2012.08.007.
• Pekiner FN, Borahan MO, Özbayrak S. Oral liken planus (OLP)’lu bireylerde kortizol, anksiyete ve depresyon düzeylerinin değerlendirilmesi. Clinical and Experimental Health Sciences.2014;4(1), 24-28. DOI: 10.5455/musbed.20140208013705 (Turkish).
• Wang J, van der Waal I. Disease scoring systems for oral lichen planus; a critical appraisal. Med Oral Patol Oral Cir Bucal. 2015;20(2): e199-204. DOI: 10.4317/medoral.20524.
• Waal I. Oral lichen planus and oral lichenoid lesions; a critical appraisal with emphasis on the diagnostic aspects. Med Oral Patol Oral Cir Bucal. 2009;14(7): E310-314.
• Au J, Patel D, Campbell JH. Oral lichen planus. Oral Maxillofac Surg Clin North Am. 2013;25(1):93-100, vii. DOI: 10.1016/j.coms.2012.11.007.
• Gobbo M, Rupel K, Zoi V, Perinetti G, Ottaviani G, Di Lenarda R, Bevilacqua L, Woo SB, Biasotto M. Scoring systems for Oral Lichen Planus used by differently experienced raters. Med Oral Patol Oral Cir Bucal. 2017;1;22(5): e562-e571. DOI: 10.4317/medoral.21833.
• Al-Hashimi I, Schifter M, Lockhart PB, Wray D, Brennan M, Migliorati CA, Axéll T, Bruce AJ, Carpenter W, Eisenberg E, Epstein JB, Holmstrup P, Jontell M, Lozada-Nur F, Nair R, Silverman B, Thongprasom K, Thornhill M, Warnakulasuriya S, van der Waal I. Oral lichen planus and oral lichenoid lesions: Diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103 Suppl: S25.e1-12. DOI: 10.1016/j.tripleo.2006.11.001.
• Koray M, Dülger O, Ak G, Horasanli S, Uçok A, Tanyeri H, Badur S. The evaluation of anxiety and salivary cortisol levels in patients with oral lichen planus. Oral Dis. 2003;9(6):298-301. DOI: 10.1034/j.1601-0825.2003.00960. x.
• Hazeldine J, Arlt W, Lord JM. Dehydroepiandrosterone as a regulator of immune cell function. J Steroid Biochem Mol Biol. 2010;31;120(2-3):127-136. DOI: 10.1016/j.jsbmb.2009.12.016.
• Stojanovich L. Stress and autoimmunity. Autoimmun Rev. 2010;9(5): A271-276. DOI: 10.1016/j.autrev.2009.11.014.
• Mozaffari HR, Ramezani M, Mahmoudiahmadabadi M, Omidpanah N, Sadeghi M. Salivary and serum levels of tumor necrosis factor-alpha in oral lichen planus: A systematic review and meta-analysis study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;124(3):e183-e189. DOI: 10.1016/j.oooo.2017.06.117.
• Mozaffari HR, Sharifi R, Sadeghi M. Interleukin-6 levels in the serum and saliva of patients with oral lichen planus compared with healthy controls: A meta-analysis study. Cent Eur J Immunol. 2018;43(1):103-108. DOI: 10.5114/ceji.2018.74880.
• Mozaari HR, Sharifi R, Sadeghi M. Prevalence of oral lichen planus in diabetes mellitus: A meta-analysis study. Acta Inform Med. 2016; 24:390–393. DOI: 10.5455/aim.2016.24.390-393
• Lopez-Jornet P, Zavattaro E, Mozaffari HR, Ramezani M, Sadeghi M. Evaluation of the Salivary Level of Cortisol in Patients with Oral Lichen Planus: A Meta-Analysis. Medicina (Kaunas). 2019;55(5):213. DOI: 10.3390/medicina55050213.
• Kaur B, Sunil MK, Trivedi A, Singla N, Garg S, Goyal,N. Salivary cortisol as a diagnostic marker in oral lichen planus. J Int Oral Health. 2015;7:43–48.
• Tvarijonaviciute A, Aznar-Cayuela C, Rubio CP, Tecles F, Ceron JJ, López-Jornet P. Salivary antioxidant status in patients with oral lichen planus: Correlation with clinical signs and evolution during treatment with chamaemelum nobile. BioMed Res Int. 2018;2018: 5187549. DOI: 10.1155/2018/5187549
• Girardi C, Luz C, Cherubini K, de Figueiredo MA, Nunes ML, Salum FG. Salivary cortisol and dehydroepiandrosterone (DHEA) levels, psychological factors in patients with oral lichen planus. Arch Oral Biol. 2011;56(9):864-868. DOI: 10.1016/j.archoralbio.2011.02.003.
• Albanidou-Farmaki E, Poulopoulos AK, Epivatianos A, Farmakis K, Karamouzis M, Antoniades D. Increased anxiety level and high salivary and serum cortisol concentrations in patients with recurrent aphthous stomatitis. Tohoku J Exp Med. 2008;214(4):291-296. DOI: 10.1620/tjem.214.291.
• Ivanovski K, Nakova M, Warburton G, Pesevska S, Filipovska A, Nares S, Nunn ME, Angelova D, Angelov N. Psychological profile in oral lichen planus. J Clin Periodontol. 2005;32(10):1034-1040. DOI: 10.1111/j.1600-051X.2005.00829.x.
• Mohamadi Hasel K, Besharat MA, Abdolhoseini A, Alaei Nasab S, Niknam S. Relationships of personality factors to perceived stress, depression, and oral lichen planus severity. Int J Behav Med. 2013;20(2):286-292. DOI: 10.1007/s12529-012-9226-5.
• Valter K, Boras VV, Buljan D, Juras DV, Susić M, Pandurić DG, Verzak Z. The influence of psychological state on oral lichen planus. Acta Clin Croat. 2013;52(2):145-149.
• Chaitanya NC, Reshmapriyanka D, Pallavi K, Ameer S, Appala A, Chowdhary A, Prabhath T, Ratna MP, Sowmya BS, Vaishnavi C, Bontala P. Serological and psychological assessment of patients with oral lichen planus using serum cortisol levels and hads questionnaire-a case control study. J Popul Ther Clin Pharmacol. 2020;27(2): e19-e27. DOI: 10.15586/jptcp.v27i2.667.
• Skrinjar I, Vidranski V, Brzak BL, Vidovic Juras D, Andabak Rogulj A, Brailo V, Vucicevic Boras V. Salivary cortisol levels in patients with oral lichen planus—A pilot case-control study. Dentistry Journal. 2019;7(2):59. DOI: 10.3390/dj7020059
• Ebrecht M, Hextall J, Kirtley LG, Taylor A, Dyson M, Weinman J. Perceived stress and cortisol levels predict speed of wound healing in healthy male adults. Psychoneuroendocrinology. 2004;29(6):798-809. DOI: 10.1016/S0306-4530(03)00144-6.
• Berk LS, Tan SA, Berk D, Berk LS. [Abstract] Cortisol and Catecholamine stress hormone decrease is associated with the behavior of perceptual anticipation of mirthful laughter. The FASEB Journal. 2008;1;22.
• Nadendla LK, Meduri V, Paramkusam G, Pachava KR. Relationship of salivary cortisol and anxiety in recurrent aphthous stomatitis. Indian J Endocrinol Metab. 2015;19(1):56-59. DOI: 10.4103/2230-8210.131768.
• Nosratzahi T, Raiesi M, Shahryari B. Lack of Association between Oral Lichen Planus and Hepatitis B and C Virus Infection - a Report from Southeast Iran. Asian Pac J Cancer Prev. 2018;19(6):1633-1637. DOI: 10.22034/APJCP.2018.19.6.1633.
• Romero MA, Seoane J, Varela-Centelles P, Diz-Dios P, Otero XL. Clinical and pathological characteristics of oral lichen planus in hepatitis C-positive and -negative patients. Clin Otolaryngol Allied Sci. 2002;27(1):22-26. DOI: 10.1046/j.0307-7772.2001.00516.x.
• Jayavelu P, Sambandan T. Prevalence of hepatitis C and hepatitis B virus infection(s) in patients with oral lichen planus. J Pharm Bioallied Sci. 2012;4(Suppl 2):S397-405. DOI: 10.4103/0975-7406.100302.
• Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244(4902):359-362. DOI: 10.1126/science.2523562.
• Mokni M, Rybojad M, Puppin D Jr, Catala S, Venezia F, Djian R, Morel P. Lichen planus and hepatitis C virus. J Am Acad Dermatol. 199;24(5 Pt 1):792. DOI: 10.1016/s0190-9622(08)80376-3.
• Song J, Zhang Z, Ji X, Su S, Liu X, Xu S, Han Y, Mu D, Liu H. Lack of evidence of hepatitis in patients with oral lichen planus in China: A case control study. Med Oral Patol Oral Cir Bucal. 2016;1;21(2): e161-168. DOI: 10.4317/medoral.20812.
• Nagao Y, Sata M. A retrospective case-control study of hepatitis C virus infection and oral lichen planus in Japan: Association study with mutations in the core and NS5A region of hepatitis C virus. BMC Gastroenterol. 2012; 12:31. DOI: 10.1186/1471-230X-12-31.
• Birkenfeld S, Dreiher J, Weitzman D, Cohen AD. A study on the association with hepatitis B and hepatitis C in 1557 patients with lichen planus. J Eur Acad Dermatol Venereol. 2011;25(4):436-440. DOI: 10.1111/j.1468-3083.2010.03809.x.
• Lin LH, Lu SY, Lu SN. Seroprevalence of anti-HCV among patients with oral lichen planus in Southern Taiwan. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109(3):408-414. DOI: 10.1016/j.tripleo.2009.10.005.
• Rotaru DI, Chisnoiu RM, Kui AI, Bolboacă SD, Chisnoiu AM. The influence of Hepatitis C virus infection on oral health-related quality of life in patients with oral lichen planus. Int J Environ Res Public Health. 2021;18(17):9382. DOI: 10.3390/ijerph18179382.
• Rebora A. Skin diseases associated with hepatitis C virus: Facts and controversies. Clin Dermatol. 2010;28(5):489-496. DOI: 10.1016/j.clindermatol.2010.03.004.
• Alaizari NA, Al-Maweri SA, Al-Shamiri HM, Tarakji B, Shugaa-Addin B. Hepatitis C virus infections in oral lichen planus: A systematic review and meta-analysis. Aust Dent J. 2016;61(3):282-287. DOI: 10.1111/adj.12382.
• Cunha KS, Manso AC, Cardoso AS, Paixão JB, Coelho HS, Torres SR. Prevalence of oral lichen planus in Brazilian patients with HCV infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100(3):330-333. DOI: 10.1016/j.tripleo.2004.11.017.
• Tenório JR, de Camargo AR, Lemos C, Ortega KL. Oral lichen planus and HCV infection. Autops Case Rep. 2020;20;10(4):e2020210. DOI: 10.4322/acr.2020.210.
• Gheorghe C, Mihai L, Parlatescu I, Tovaru S. Association of oral lichen planus with chronic C hepatitis. Review of the data in literature. Maedica (Bucur). 2014;9(1):98-103.
• Gerayli S, Meshkat Z, Pasdar A, Mosannen Mozafari P, Banihashemi E, Khajavi MA, Rasekhi J. The association between oral lichen planus and hepatitis C virus infection; a report from northeast of Iran. Jundishapur J Microbiol. 2015;18;8(4):e16741. DOI: 10.5812/jjm.8(4)2015.16741.
• Ali AA, Suresh CS. Oral lichen planus in relation to transaminase levels and hepatitis C virus. J Oral Pathol Med. 2007;36(10):604-8. DOI: 10.1111/j.1600-0714.2007.00581.x.
• Bombeccari GP, Tettamanti M, Pallotti F, Spadari F, Giannì AB. Exacerbations of oral lichen planus and elevated levels of aminotransferases. Int J Dermatol. 2017;56(8):842-849. DOI: 10.1111/ijd.13626.
• Özbayrak, S. Ağız hastalıkları atlası: Tanı kriterleri, ayırı tanı ve tedavi yaklaşımları (4. Baskı). 2020.Quintessence: İstanbul (Turkish).
• Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z, Akarca U, Kaymakoglu S, Ergonul O. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: A fieldwork TURHEP study. Clin Microbiol Infect. 2015;21(11):1020-6. DOI: 10.1016/j.cmi.2015.06.028.